U.S., Dec. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07311317) titled 'Cellular-Level Fluorescence Imaging for Intraoperative Margin Assessment in Breast Cancer' on Dec. 02.
Brief Summary: Accurate intraoperative margin assessment in breast cancer surgery remains challenging. Current reliance on frozen section pathology is limited by prolonged processing time, sampling constraints, and resource intensity, contributing to variable outcomes.
The EndoSCell Scanner is a novel cellular-resolution fluorescence-guided imaging technology designed to address these limitations. It enables real-time, pathology-level visualization of malignant cellular features at the surgical bed. With a 3mm probe allowing compr...